AstraZeneca OKs Sandoz Cancer-Drug Generic For 2019
Sandoz Inc. will be able to release a generic version of AstraZeneca's breast cancer drug Faslodex at the end of March 2019, according to a patent infringement settlement approved by a...To view the full article, register now.
Already a subscriber? Click here to view full article